Survey indicates more take‐homes preferable to on‐site dosing

Longer days of take‐home methadone are rare, and this is not good, a recent report states. Take‐home guidelines should be established with social vulnerability taken into account, the study's researchers wrote. The researchers studied the relationship between state take‐home policies and social vulnerability on take‐home methadone receipt and days’ supply. The data came from the VOICES study, a telephone survey conducted between January 2023 and August 2024 of people who use drugs, from Wisconsin, Michigan, New Mexico and New Jersey. More than half of the participants (n = 428) received take‐home methadone (average three days’ supply); 19% of take‐home recipients (54) received three or more days of take‐homes. The study, “Differences in Take‐Home Methadone Receipt by State Policy and Individual Social Factors in a Multistate Survey of People Who Use Drugs: A Cross‐Sectional Study,” was authored by Olivia K. Sugarman and colleagues and published int tk.